Aratana Therapeutics Reports First Quarter 2016 Financial Results
Go back to Aratana Therapeutics Reports First Quarter 2016 Financial Results| Lilly (Eli) & Co. (NYSE: LLY) | Delayed: 1179.11 +9.94 (0.85%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1169.17 | 52 Week High | $88.16 | |||
| Open | $1159.44 | 52 Week Low | $67.88 | |||
| Day High | $1187.95 | P/E | 272.94 | |||
| Day Low | $1151.01 | EPS | $4.32 | |||
| Volume | 2,757,310 | |||||
| ARATANA THERAPEUTIC (NASDAQ: PETX) | Delayed: 4.92 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.92 | 52 Week High | $10.73 | |||
| Open | $11.31 | 52 Week Low | $2.56 | |||
| Day High | $4.92 | P/E | N/A | |||
| Day Low | $4.92 | EPS | $-1.01 | |||
| Volume | 899 | |||||

